All Resources
Application Note: Directly Link T Cell Phenotype and Function to Genotype with the Opto Cell Therapy Development 1.0 Workflow
Review use cases for CAR-T cell screening and TCR discovery.
Poster: Plasma B Cell Cloning
Berkeley Lights and ChemPartner provide a case study in accelerated discovery of unique Anti-PD-L1 antibodies from spleen versus bone marrow of immunized mice, via single plasma B cell cloning on the Beacon platform.
Poster: T Cell Functional Analytics on the Lightning Platform
See how you can rapidly visualize and analyze thousands of cell-cell interactions in a single-day workflow with live cell recovery.
Webinar: Antibody Engineering & Therapeutics Digital Week 2019
Learn about accelerating target-to-lead antibody candidate selection with the Beacon platform in this Antibody Engineering & Therapeutics Digital Week 2019 webinar.
Datasheet: Opto™ CLD 2.0 Workflow
Overview of the Opto CLD 2.0 workflow and representative results.
Datasheet: Culture Station
Learn how you can increase scope, scale, and throughput of workflows run on the Beacon and Lightning platforms.
Cell Line Development Webinar: Digital Week 2019
Learn about improved and expedited cell line development on the Beacon platform from Biogen’s Rachel Ferguson.
Poster: T Cell Functional Analytics
This poster describes in detail how to sequence and clone IDH1 R132H targeted monoclonal T cell receptors from CD4+ T cells, using the Beacon system.
Webinar: BPI Digital Week 2018
Watch a 1-hour webinar from the 2018 BioProcess International Digital Week titled, “Implementing the Beacon Platform for the Next Generation of Cell Line Development,” featuring scientists from Berkeley Lights and Catalent Biologics.
Antibody Discovery Webinar: Digital Week 2018
Watch a 1-hour webinar from the 2018 Antibody Engineering & Therapeutics Digital Week titled, “Emerging Technologies for Finding Rare Antibodies,” featuring scientists from Berkeley Lights and Teva Pharmaceuticals.
Poster: Rapid Antibody Discovery on the Beacon System
This poster developed by Berkeley Lights and Pfizer demonstrates rapid antibody discovery on the Beacon platform, showing how it can rapidly isolate and screen thousands of primary ASCs in a single day.